Treace Medical Concepts, Inc.: Stifel raises to buy from hold; raises target price to $6.5 from $4.5
TMCI•Stifel raised its rating on Treace Medical Concepts to buy from hold and its target price to $6.50 from $4.50.
Related News
Tevogen extends borrowing period for $28.6 million Patel family loan facility to May 2029
TVGN•
Goodyear appoints Roger Wood interim CEO; shares down
GT•
Whitehawk Therapeutics Q3 net loss widens on R&D expenses
WHWK•
Koppers Holdings Inc: B. Riley cuts target price to $54 from $62
KOP•
Mirion to present at Baird’s Global Industrial Conference
MIR•